OPEN END-TURBO-OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 13:35:13 2024-07-02 EDT | ||
| 8.67 EUR | -1.03% |
|
| Current month | -1.46% | ||
| 1 month | +6.96% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-02 | 8.67 | -1.03% |
| 24-07-01 | 8.76 | -1.46% |
| 24-06-28 | 8.89 | -1.11% |
| 24-06-27 | 8.99 | -0.88% |
| 24-06-26 | 9.07 | -5.82% |
Real-time BOERSE MUENCHEN
Last update July 02, 2024 at 01:35 pm
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | HSBC |
| WKN | TT3YEJ |
| ISIN | DE000TT3YEJ2 |
| Date issued | 2020-10-30 |
| Strike | 217.4 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.23 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.65 € |
|---|---|
| Lowest since issue | 0.63 € |
| Spread | 0.02 € |
| Spread % | 0.23% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
311
USD
Average target price
316.4
USD
Spread / Average Target
+1.75%
- Stock Market
- Certificates
- Certificat
